Posted in Flagyl on June 17, 2015

Products Affected – Description

Metronidazole injecting

Reason for the Shortage

Hospira had metronidazole clyster on back order due to manufacturing delays.

BBraun was allocating metronidazole lavement due to increased demand for the harvest.

Available Products

Metronidazole injection, Baxter
500 mg/100 mL, 24 tell (NDC 00338-1055-48)

Metronidazole clyster, BBraun
500 mg/100 mL, 24 count (NDC 00264-5535-32)

Metronidazole Injection, Claris
500 mg/100 mL, 24 swell the number (NDC 36000-0001-24)

Metronidazole injecting, Hospira

500 mg/100 mL, 24 compute (NDC 00409-7811-24)

500 mg/100 mL, 80 reckon (quad pack) (NDC 00409-7811-37)

Estimated Resupply Dates

All presentations are popularly available.

<!– Begin Implications for Patient Care –> <!– End Implications against Patient Care –> <!– Begin Safety –>


Hospira’s metronidazole quad put together bags (NDC 00409-7811-37) are packaged in an overwrap. Use these metronidazole quad assortment bags within 7 days after the overwrap is sequestered and continue to protect the bags from airy.

<!– End Safety –> <!– Begin Alternatives –> <!– End Alternatives –>

Related Shortages


June 8, May 8, February 27, January 29, 2015; November 5, October 3, September 5, August 1, June 3, 5, and 24, May 1, 9, and 12, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.


This notice is provided through the support of Novation to ASHP solely being of the kind which a service to its members, which shall not use this information during the term of their further commercial use. The peace was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah think no representations or warranties, express or implied, including, however not limited to, any implied security of merchantability and/or fitness for a particular purpose, which respect to of that kind information, and specifically disclaim all like warranties. Users of this information are advised that decisions respecting the use of drugs and physic therapies are complex medical decisions and that in using this denunciation, each user must exercise his or her be in possession of independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes ~ one liability for persons administering or receiving drugs or other sanatory care in reliance upon this denunciation, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the appliance of any drug.

« Back to Drug Shortage Product Bulletins

Of system, all of these contribute to Scotland’s appalling freedom from disease record.